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1. Introduction  
Looking back into the history of mankind, one is often startled to find the emergence of 
some outstanding personalities at different intervals of time. Their thoughts and futuristic 
viewpoints revolutionized the existing perspective in the fields of science, philosophy and 
social order. The embodiment of such a personality in the field of medicine was Samuel 
Christian Friedrich Hahnemann, the father of homeopathy. He was born on the 10th April 
1755 in the small town of Meissen, near Dresden in Germany. A doctor in the conventional 
medicine of his time, by 1790 he was recognized as one of the most distinguished physicians 
of his generation and was appointed physician to the king. Soon however, he became 
dissatisfied with contemporary medical ideas and the often cruel practices that ensued, as 
well as the drugs being prescribed. He realized that many of these medicines owed their 
pride of place in the Materia Medica due to their very biologically active nature, which 
could easily occasion death or produce new diseases on whomever they were applied. 
Disillusioned, Hahnemann renounced his practice of medicine. While engaged in translating 
a treatise on herbal medicine, he felt dissatisfied with the explanation given for the cure of 
malarial fever by giving cinchona bark. He took the drug himself in order to investigate the 
changes induced by it on his healthy system. Peculiarly, the symptoms of malaria made 
their appearance in him, one after the other, but without the chilly rigor. This reminded him 
of Hippocrates’ aphorism, “Similia similibus curentur,” meaning “Let likes be cured by likes” 
(Hobhouse, 2002). 
Hahnemann felt convinced that the drug, which was the best agent to cure malarial fever, 
produced in him the initial symptoms of that fever. He then investigated the action, on 
healthy human beings, of as many as 50 more drugs over a period of six years. He recorded 
the symptoms produced, and compared them with the symptoms of diseases against which 
they were used successfully.  
1.1 What is homeopathy? 
In 1776, Hahnemann published the results of his findings in a paper entitled “Essay on the 
new principle for ascertaining the curative power of drugs.” In this, he postulated the most 
important principle of homeopathy, stating, “Every powerful medicinal substance produces in 
the human body a kind of peculiar disease, the more powerful the medicine, the more particularly 
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marked and violent the disease. We should imitate nature, which sometimes cures a chronic disease, 
by superadding another, and employ in the disease (especially chronic) we wish to cure, that medicine 
which is able to produce another very similar artificial disease, and the former will be cured similia 
similibus.” In 1810, he published The Organon of the Rational Art of Healing, his greatest book, 
wherein he elucidated systematically the methods and principles of a system of medical 
treatment to which he had given the name of “Homeopathy” (Hahnemann, 1982).  
The homeopathic approach is holistic, that is, while treating a patient a homeopath will 
consider not only the disease, but the whole constitution of the patient. The patient is treated 
as a whole. To know about homeopathy we should know what “individualization” and 
“similimum” mean because these two are the basic tenets on which selection of homeopathic 
medicines depends, as practised and taught from the time of Hahnemann.  
What is “individualization”? Every individual person is different from the other physically, 
mentally, constitutionally and in their likes and dislikes. In general, we may find some 
persons alike, but all individuals have their own special features. “Similimum” means the 
most similar medicine as per symptoms narrated by a patient. After noting down the 
symptoms of a patient the physician thinks of a few medicines out of which he finds one 
medicine which appears to be the most similar to the symptoms narrated, considering the 
mental and constitutional status for that particular individual. In classical homeopathy only 
a single medicine is given in a single dose and then the patient is observed for his/her 
response. 
Classical homeopathy has, therefore, no specific remedy for any disease by name, but it has 
specificity for each individual case of disease. A specific drug cannot be used for a specific 
disease. In general, when a homeopathic physician examines a patient, only a few medicines 
come to his mind. This small group of medicines exhibits similar symptoms when given to 
healthy subjects for pharmacological testing (a process called “proving.”.. Finally only one is 
selected as a result of practical experience and this procedure requires a long and intense 
interrogation of the patient. In an interesting study of homeopathic diagnosis and treatment, it 
was shown that a typical classical homeopathic initial consultation took 117 +/- 43 minutes for 
each adult patient and 86 +/- 36 minutes for each child patient. Theoretically there should be 
only one such medicine considering the entirety of the patient (Becker-Witt, et. al., 2004).  
The homeopathic drug is not administered in usual pharmacological doses, but in minute 
doses prepared according to certain principles. These medicines are produced using various 
plant extracts, salts, animal products, minerals etc. and then diluting the extracted mother 
tincture or the crude materials, per pharmacopoeial methods. These solutions are serially 
diluted and succussed (agitated) until the desired potency is produced. Greater dilution 
leads to greater potency of the medicine. The crude or slightly diluted extract when ingested 
by healthy volunteers produces symptom complexes that mimic various diseases. The 
symptoms produced and recorded are a result of the dynamic action of drugs on healthy 
volunteers or “provers.” The symptoms produced by the drug in provers are exactly what 
the potentized medicine is prescribed for in the sick. 
1.2 The central problem of classical homeopathy 
Although classical homeopaths believe that the above-described method of selecting 
medicines is essential to the worth of their medical system, the central problem is, whether a 
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correct similimum can be selected by such a method of individualization. The subjective 
symptoms elicited in the typical two-hour initial consultation are often “lost in the 
translation.”Thus, should a patient be examined separately by different homeopaths on the 
same day, he will be perplexed to find that none of them seem to agree as to the so-called 
“similimum.” Then how can individualization be explained logically and used to benefit the 
suffering population? Do all the medicines suggested by various homeopaths for a patient 
behave as a similimum for that particular case? Obviously not! Then what is the solution to 
this central question of how the correct medicine should be determined? The answer is to 
rationalize the selection of medicines based on previous experience and experimentation 
and to develop routine treatment protocols following a scientific method for selecting 
medicines. Another practical problem may be mentioned here. If a homeopath examines six 
or eight cases daily, he may have to charge high fees from each individual patient for 
maintenance. This will put homeopathy out of reach to the suffering population who really 
need it. At the same time, with such a small number of patients, a homeopath hardly gets 
enough clinical experience to become a true physician. It is common knowledge that 
experience makes a doctor. 
Scientific validation of the efficacy of homeopathic medicines, which are nontoxic and 
inexpensive - making them ideal as “the People’s Medicine” - has been stalled due to the 
inability to conduct clinical trials using standardized treatment protocols with these 
medicines. The true healing potential of homeopathy, then, has been repeatedly challenged 
and denied by mainstream medicine because of this problem. Thus, this system of medicine 
is at risk of being delegated to the archives of history. 
1.3 The Banerji Protocols 
In the clinics of our research foundation,, we do not practice classical homeopathy. We have 
developed a method of treatment in which specific medicines are prescribed for specific 
diseases. Diseases are diagnosed using modern state-of-the-art scientific methods. This is 
done because modern diagnostic approaches incorporate and help in the selection of 
medicines so that specific medicines can be easily prescribed for specific diseases. With the 
passage of time and the availability of new diagnostic tools like ultrasonography, magnetic 
resonance imaging, cancer biomarkers and other advanced tests, we have been able to 
further streamline the treatment protocols. The efficacy of this approach is reflected by the 
encouraging results of our new method of treatment, which we call the “Banerji Protocols.” 
We often combine two potentized medicines and use the combination in our practice. This 
combination of two potentized medicines is made in a meaningful way based on years of 
clinical observations by us. Medicines are combined for special advantages in treatment, so 
that the aggravation due to the medicines can be checked, side effects of the medicines 
abated, and quick and uneventful recovery can be ensured in a much shorter time. We will 
discuss the Banerji Protocols in more depth later in this chapter.  
2. The global use of homeopathy 
Homeopathy currently is used in over 80 countries around the world. In several countries 
including India, Mexico, Brazil and the UK homeopathy is integrated into the healthcare 
systems. In the United States, homeopathic remedies are regulated as nonprescription 
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drugs, which give them a unique status over other natural therapies and supplements. 
Homeopathy is very popular in the UK, where the Royal Family has had homeopathic 
physicians since the 1830s. In England, as many as 45% of conventional MDs refer patients 
to homeopaths and the treatment is part of the National Health Scheme (NHS). In France, 
40% of the population use homeopathy. Thirty thousand French doctors use homeopathic 
medicines, there are twenty thousand pharmacies providing them, and 32% of French 
family physicians use homeopathy. In Italy, homeopathy is the most popular alternative 
therapy, used by 86% of the population. In Germany 25% of family physicians use 
homeopathy, and non-MD homeopaths are eligible for licensure and until recently were 
reimbursed by the National Health System. Nine million people use homeopathy in Brazil. 
In 1985, homeopathy was included among the therapeutic options offered at the outpatient 
facilities of the Brazilian public health system. Fifteen thousand Brazilian doctors practice 
homeopathy (Marino, 2008).  
In Asia, the homeopathic medical system is very popular, especially in India, Pakistan and 
Sri Lanka. The epoch-making statement of Mahatma Gandhi, "Homeopathy.... cures a larger 
percentage of cases than any other method of treatment and is beyond doubt safer and more 
economical and most complete medical science,” added another feather to the cap of 
homeopathy. In India today there are 162 degree colleges teaching homeopathy and the 
largest pool of homeopaths in the world – over 200,000 doctors practice homeopathy. About 
100 million people use homeopathy (Ghosh, 2010; Singh, 2005). This is a very conservative 
estimate because in the 1950ss and 1960s there were not many conventional doctors 
available for the treatment of the masses. In that era, most village school masters and 
scholars educated themselves in this economical and easy to administer treatment form. 
Thus homeopathy had a much further reach amongst the general population than 
conventional medicine. Of India’s 1.16 billion population, approximately 70% live in villages 
and rural areas, where access to expensive conventional medical facilities is limited (World 
Health Organization, 2006).  
3. History of homeopathy in India 
Seen through the mist of years, the early history of the advent of homeopathy in India is a 
fascinating episode. As early as 1810, some German missionaries landed in Bengal. They 
used to distribute homeopathic remedies among the poor people to alleviate their 
sufferings. Slowly the elite of society recognized its efficacy and many civil servants and 
military personnel became amateur homeopaths. On the other hand, due to the efficacy and 
affordability of the medicines, in the rural environment many school teachers also took to 
reading the homeopathic materia medicas and prescribing to their village communities. In 
1852 John Martin Hoenigberger, who was initiated into homeopathy by Hahnemann himself 
in Paris in 1835, published a book which gave a glimpse of the beginning of Indian 
homeopathic practice in Lahore, at the court of Maharaja Ranjit Singh. In his chronicles, he 
gives a vivid account of his successful treatment of Maharaja Ranjit Singh’s chronic disease 
of partial paralysis (Hoenigberger, 1852). 
During the second half of the nineteenth century some homeopathic dispensaries were 
opened in Bengal and in the south. The pioneer in this field in Calcutta was Rajendralal 
Dutta (1818-1889). He belonged to a scholarly and aristocratic family of Bengal. He engaged 
a French doctor, Dr. Tonnere, and placed him in charge of a homeopathic hospital and 
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dispensary in Calcutta in 1852. Unfortunately, this venture failed. Subsequently Rajen Dutta 
himself took up the cudgel and started practice in homeopathy. Among his illustrious 
patients may be mentioned the great early social reformer Pandit Ishwarchandra Vidyasagar 
and Raja Radhakanta Dev Bahadur. Rajen Dutta cured Pandit Vidyasagar of a migraine 
which the conventional system had failed to cure. Furthermore the cure of a gangrenous 
ulcer of Raja Radhakanta Dev Bahadur created a sensation in Calcutta at the time. 
In order to strengthen the roots of homeopathic practice in India, Dutta looked around for a 
suitable person of eminence. His efforts were crowned with success when he was able to 
persuade Dr. Mahendralal Sircar, medical doctor and skeptic of homeopathy, to test its 
scientific efficacy and curative potential. In his experiment, administration of homeopathic 
medicines became effective even when Dr. Sircar's conventional medicine failed. Thus Dr. 
Sircar became converted to homeopathy and carved a niche for it in the medical history of 
India. A number of allopathic doctors started homeopathic practice following Sircar's lead. 
The Calcutta Homeopathic Medical College, the first homeopathic medical college, was 
established in 1881. This institution took on a major role in popularizing homeopathy in 
India (Ghosh, 2010). 
Gradually homeopathic dispensaries opened in other cities like Benares and Allahabad, and 
by the beginning of the twentieth century homeopathy had spread all over India. In 1973, 
the Government of India recognized homeopathy by setting up the Central Council of 
Homeopathy (CCH) to regulate its education and practice. Now, only qualified registered 
homeopaths can practice homeopathy in India. At present, in India, homeopathy is probably 
the most popular system of medicine, due to the fact of its easy administration in the home 
setting and its affordability.  
4. Cancer and homeopathy  
The role and efficacy of homeopathic medicines for treatment of malignant tumors is largely 
unknown and unproven so far. Homeopathic therapy is mainly used for supportive cancer 
care and some have suggested an integration of this therapy with conventional methods 
(Kassab, et al., 2009). However, in numerous studies, it has been found that orthodox 
medicine is not meeting the needs of some patients and that Complementary and 
Alternative Medicine (CAM) may wholly or partly substitute for conventional medicines. 
Most patients indicate that their problems improve with CAM (Ernst, 2005; Frenkel, 2010). 
Cancer is a subject of great concern because there is a lack of effective treatment even in the 
21st century. Along with a search for conventional solutions, researchers are actively trying 
to identify treatment options offered by various systems of complementary and alternative 
medicine, including homeopathy. We believe that the Banerji Protocols have an important 
role to play in this effort. 
A comprehensive worldwide survey of studies of the use of complementary and alternative 
medicine by cancer patients concluded that its use is common and widespread. Within this 
broad arena of therapies, homeopathy is consistently listed as one of the systems chosen by 
patients with cancer (Ernst, 2000). A large descriptive survey of cancer patients in Europe 
found that on average 35.9% were using some form of complementary or alternative 
therapy. Homeopathy was the most commonly used of these therapies in Belgium and was 
in the top five choices in six other countries. In other European countries, it was second only 
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to herbal medicines. In France, a recent study in an oncology department revealed that 34% 
of the patients were using complementary medicine and homeopathy was the most 
frequently used of these (Träger-Maury, 2007). Homeopathy is one of the eight most 
popular complementary therapies used by cancer patients in the UK (Chang, 2011). 
A recently reported European study conducted a prospective one-year observational study 
of cancer patients comparing one cohort of 259 patients under homeopathic treatment with a 
matched cohort of 380 patients undergoing conventional treatment. Outcomes compared 
included quality of life (QOL), fatigue, and anxiety/depression. The researchers found a 
significant improvement in quality of life in the homeopathy group after three months and a 
continued improvement after twelve months. The conventionally treated group had no 
improvement in one QOL scale after three months and a slight improvement in the other 
QOL scale; at twelve months there was a slight increase in one indicator and a decrease in 
the other. Fatigue and anxiety/depression were not improved in the conventionally treated 
group; fatigue but not anxiety/depression improved in the homeopathy group (Rostock, et 
al., 2011). A meta-analysis of all clinical studies on cancer treatment outcomes using 
homeopathy (Milazzo et al., 2006) found that all studies examined were investigating the 
use of homeopathy for adjunctive symptom treatment, not as primary antitumor treatment.  
There are a number of in vitro and in vivo studies, however, that have investigated the 
antitumor activity of homeopathic medicines. In India, the laboratory of Khuda-Bukhsh has 
reported a significant anti-tumor effect of homeopathically prepared Chelidonium and 
Lycopodium (Banerji, A., et al., 2010; Pathak, S. et al., 2006). In America, several studies have 
reported the in antitumor effect of five homeopathic remedies used for treatment of prostate 
cancer. There was a 23% reduction in tumor incidence, and for animals with tumors, there 
was a 38% reduction in tumor volume in homeopathy-treated animals versus controls 
(Jonas, W.B., 2006). However, in another study there were no direct cellular anticancer 
effects demonstrated in these researchers’ in vitro and in vivo studies (Thangapazham, R.L., 
2006). A third study examined in vivo effects on mice treated with homeopathically prepared 
Sabal serrulata and clearly demonstrated a biologic response to homeopathic treatment as 
manifested by cell proliferation and tumor growth. Two other homeopathic medicines 
tested did not show similar anti-tumor effects (MacLaughlin, B.W., 2006). Another study 
done in India reported that homeopathic drugs retarded liver tumor growth in mice and 
reduced the incidence of chemically-induced sarcomas and also increased the life span of 
mice harboring these tumors (Kumar, K.B., 2007). What we see in this review of laboratory 
research of homeopathy is consistent reports of its effectiveness in slowing tumor growth in 
mice without a clear mechanism of action being demonstrated.  
Our own studies done in collaboration with American researchers at the M.D. Anderson 
Cancer Center, University of Texas must be mentioned at this point, for they have 
demonstrated plausible biological mechanisms for the antitumor effects of the homeopathic 
medicines tested. In one report we described 15 patients diagnosed with documented 
intracranial tumors who were treated exclusively with the homeopathic remedies Ruta 
graveolens 6c and Calcarea phosphorica 3X without additional chemotherapy or radiation. Of 
these 15 patients, six of the seven who had glioma showed complete regression of the 
tumors. In this study we also reported that these medicines stimulated induction of 
survival-signaling pathways in normal lymphocytes and induction of death-signaling 
pathways in brain cancer cells. Cancer cell death was initiated by telomere erosion and 
www.intechopen.com
 Homeopathy: Treatment of Cancer with the Banerji Protocols 
 
129 
completed through mitotic catastrophe events (Pathak, S., 2003). More recently we reported 
a study of four homeopathic remedies that we use for treating breast cancer against two 
human breast adenocarcinoma cell lines (MCF-7 and MDA-MB-231) and a cell line derived 
from immortalized normal human mammary epithelial cells. The remedies exerted 
preferential cytotoxic effects against the two breast cancer cell lines, causing cell cycle 
delay/arrest and apoptosis. These effects were accompanied by altered expression of the cell 
cycle regulatory proteins, including downregulation of phosphorylated Rb and 
upregulation of the CDK inhibitor p27, which were likely responsible for the cell cycle 
delay/arrest as well as induction of the apoptotic cascade that manifested in the activation 
of caspase 7 and cleavage of PARP in the treated cells (Frenkel, et al., 2010).  
5. Evolution of the Banerji Protocols 
Research in homeopathy and the introduction of Homeopathic medicinal mixtures in India 
are due to the late Dr. Pareshnath Banerji, nephew of illustrious Pandit Ishwarchandra 
Vidyasagar, who himself happened to be an ardent follower of homeopathy after his above-
described cure. Dr. Banerji started his charitable clinic in a remote village, Mihijam, situated 
in the border of Bihar in 1918 and soon became a legend. He achieved phenomenal success 
against all kinds of disease. He could declare with certainty that he would cure both acute 
and chronic conditions of innumerable common people, who congregated at his village 
clinic seeking relief from all variety of illnesses. Treating his patients gratis, he naturally had 
to deal with a vast number of patients every day. If he had followed the classical 
homeopathic approach to case assessment, he would have been able to examine at most a 
dozen patients a day. He found that about 80% of his patients suffering from common 
ailments were curable by specific homeopathic remedies, making his clinical dispensation as 
quick as lightning. For the remaining 20%, he gave the greatest importance to symptoms 
narrated by the patients themselves. Thus he achieved success through sheer practical 
experience. He did not always adhere to Hahnemann’s dictum of “Single simple and 
minimum.” He did not mind prescribing mixtures of remedies or frequent repetitions of the 
remedies when required. 
5.1 The Banerji Protocols: What are they? 
Homeopathy as a school of medicine is very young, only 200 years old. Our family has been 
associated with it for over 150 years. It can be said that the Banerji Protocols are the fruit of a 
cumulative experience and careful analysis of observed trends in patient – medicine interaction and 
the translation of the same into a system of prescribing with a view to standardize and make easy the 
practice of an extremely complex system of medicine using ultradilute medicines.  
The use of specific medicines in specific potencies, in fixed dosage patterns, eliminates the 
necessity for any guess work on the part of novice practitioners and is always a tremendous 
help for even seasoned doctors. Our approach is more diagnostic than individualistic, i.e. 
more objective than subjective. These protocols are easy to learn and since the focus is on the 
diagnostic approach the case-taking time is shortened. That is why it is easy to disseminate 
to medical students and the general public. In a short time more patients can be treated. 
Consequently, it also makes the treatment affordable to the weaker sections of society, 
making it “The People’s Medicine.” For any scientific medical system it is a rule that 
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interventions should be repeated with almost the same result – meaning, a treatment should 
have replicability - and the Banerji Protocols fulfill this criterion. 
5.2 The Banerji Protocols (BP) in the treatment of cancer 
In our clinic in Kolkata, India, an average patient turnout of 1000 to 1200 a day gives us a 
clear perspective as to disease and treatment trends in the population we serve. We treat an 
average of 10 to 15% of our patient turnout - 120 to 200 cancer cases a day – whose suffering 
from this dreaded disease has helped us to formulate set protocols for their treatment. At 
present, patients from more than seventy countries follow the Banerji Protocols for 
treatment of their cancer through the website www.pbhrfindia.org, seeking online medical 
advice and treatment. In our clinics we are privileged to have the opportunity to treat every 
type of cancer and every stage of the disease. The majority of our patients opt to take only 
our treatment without any conventional treatments and we also have patients who use our 
medicines as adjunct therapy along with or after conventional treatments fail. We often also 
have patients who come to us to seek relief from the various side-effects of conventional 
chemotherapy and radiation. Our protocols for the different types of cancer are mostly 
customized according to the location and tissue type, and the specific medicines, in their 
specific dilutions and dosage patterns, have been standardized by us. 
5.3 The Banerji cancer treatment protocols 
The main objective we follow while taking on the treatment of our cancer cases is to provide 
them with a better quality of life and, if possible, to provide a permanent cure. The Banerji 
Protocols are designed taking into account the diagnosis as well as the various complaints 
being suffered by the patients. We give a basic set of medicines to treat each cancer type and 
have 1st line, 2nd line and in most scenarios 3rd line medicines already thought out and 
designated. This is complemented by preset medicines to give palliative relief to the 
suffering of the patients brought on by accompanying symptoms. This is the basis of the 
Banerji Protocols, where quality of life is given paramount importance. The medicines that 
we use for different types of cancer are listed in detail in Table 1, but require an insight into 
cancer care for the practitioner in terms of pathology and the cause and effect of the morbid 
situation affecting the individual.  
 
Type of Cancer First line Second line Third line Related 
Symptoms 
Symptomatic 
treatment 
Brain Ruta 
graveolens 
6C, 2xday  
Calcarea phos 
3X, 2xday 
  Seizures, 
headache 
Arnica montana 
3C + Cuprum 
metallicum 6C 
    Confusion Helleborus 30C 
liq. 2xday 
    Cerebral edema Lycopodium liq. 
30C 2xday 
    Hemoptysis Ferrum phos 3X 5 
tablets SOS 
    Pleural effusion Lycopodium 30C 
liq. 3xday 
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Type of Cancer First line Second line Third line Related 
Symptoms 
Symptomatic 
treatment 
Breast cancer Phytolacca 
200C 2xday 
Carcinosin 
30C, on 
alternate 
night 
Phytolacca 
200C 2xday 
Carcinosin 
30C, on 
alternate night 
Conium 
maculatum 3C, 
2xday 
Stop the above 
medication and 
start with a new 
protocol 
Thuja 
occidentalis. 
30C, 2xday 
In agressive 
open ulcer with 
offensive 
discharge 
Psorinum 1000c 
on alternate 
morning and 
Antimonium 
crudum 200c  
 + 
Arsenicum 
album 200c 
4xday 
Esophageal 
carcinoma 
Condurango 
30C liq. 4xday 
Nitric Acid 3C 
liq. 2xday 
Carbo animalis 
200C liq. 2xday 
Staphysagria 
30C liq. 6xday 
  
Prostate cancer Thuja occ. 
30C 4xday 
Carcinosin 
30C, on 
alternate 
night 
Medorrhi-num 
200C 2xday 
Cantharis 200C 
2xday 
Conium mac. 
1000C liq. 
1xweek 
Sabal serrulata 
Q liq. 2xday 
Carcinosin 
30C,alter-nate 
nights 
Hematuria Geranium 
maculatum Q liq. 
3xday  
If this fails then 
Hamamelis 
virginica Q liq. 
4xday 
Prostate (cont’d)    Dysuria Chimaphila 
umbellata Q liq. 
every 1to 2 hours  
Pancreas cancer Carduus mar. 
Q liq. & 
Conium mac. 
3C liq.  
every 3 hours 
alternately 
Chelidonium 
majus 6X liq. 
3xday 
Hydrastis Q 
liq. & 
Chelidon-ium 
6X liq. 
every three 
hours 
alternately 
 
   
Liver cancer Hydrastis 
canadensis Q 
liq. & 
Chelidon-ium 
majus 6X liq. 
every 3 hours 
alternately 
Conium 
maculatum 
3C, 2xday 
Myrica Q liq. & 
Hydrastis 
canadensis Q 
liq. 
every 3 hours 
alternately 
Carduus 
marianus Q 
liq. 2xday 
 
   
Rectal cancer Nitric acid 3C 
liq. 6xday 
Hydrastis 200C 
&  
Mercurius 
solubilis 200C, 
every 3 hours 
alternately 
Thuja occ. 30C 
2xday 
 
Involuntary 
stool  
Veratrum album 
200c every 3 
hours 
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Type of Cancer First line Second line Third line Related 
Symptoms 
Symptomatic 
treatment 
Stomach cancer 
 
 
 
Stomach (cont’d) 
Arsenicum 
alb. 3C liq. 15 
minutes 
before food. 
plus 
Hydrastis Q 
liq. 2xday 
Conium 
maculatum 3C, 
2xday 
Hydrastis Q 
2xday 
   
Uterus, 
Cervix,Ovary 
and Appendages 
cancer 
Carbo 
animalis 
200C, 3xday 
Arnica 
montana 3C, 
3xday 
Kreosotum 
200C, 4xday 
Kreosotum 
200C, 4xday 
Conium 
maculatum 3C, 
2xday 
  
Osteosarcoma Symphy-tum 
offic. 200C, &  
Calcarea phos 
3X, every 
3 hours 
alternately 
Carcinosin 
30C, on 
alternate 
nights 
Ruta 
graveolens      
200C, 
&  
Calcarea 
phosphorica 
3X, every 
3 hours 
alternately 
   
Colon cancer Hydrastis Q 
liq. 
&  
Nitric acid 3C 
liq. 
every 3 hours 
alternately 
Conium 
maculatum 3C 
& 
Hydrastis 200C 
every 3 hours 
alternately 
 
Carbo animalis 
200C, 4xday 
Ferrum phos 3X 
+ Calcarea 
Fluorica 3X , 
2xday 
Bleeding per 
rectum 
Hamamelis 
Virginica Q liq. 
SOS after every 
bleeding 
    Palpable lump 
in abdomen 
Conium 
maculatum 3C 
liq. 1xweek 
 
 
Throat cancer – 
pyriform fossa 
and allied parts 
Nitric acid 3C 
liq, 4xday 
Hepar sulphur 
200C 
4xday 
Also Hydrastis 
Canadensis 
200c 2xday 
Thuja occ. 30C 
2xday 
Kali muriaticum 
3X, 4xday 
 
Acute painful 
deglutition 
Mercurius 
cyanatus 200C,  
3xday 
Tongue and 
Cheek cancer 
Nitric acid 3C 
liq, 4xday 
Nitric acid 3C 
liq, 4xday 
Cistus 
canadensis. 
200C liq.  
Mercurius 
cyanatus 200C 
liq. 1xday 
Kali muriaticum 
3X, 4xday 
  
Table 1. Banerji Protocols for treatment of selected cancers. One dose is 2 pills, tablets or 
drops unless otherwise specified. In Europe, C is equivalent to CH or CK; X is equivalent to 
D or DH.  
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5.4 The data collection project of the PBHRF – A unique platform for the research 
community 
In our research foundation the main research activity consists of recording in our electronic 
data base the treatment and response of all cases of various types of cancer and other life-
threatening diseases treated at our clinics. To this end, we maintain a recently upgraded, 
state-of-the-art computer network with a high-end server and five nodes. Our system also 
has two stand-alones for internet access and image processing and storage. At present our 
patient database running on customized software on Oracle and MS Visual Basic has more 
than 20,000 cases inputted with more than half a million visits recorded. The data consists of 
approximately 60 cancer types by site, including two cases of cancer of the heart. This data is 
the epicenter of the PBHRF and makes us attractive to researchers from premiere 
institutions throughout the world. Clinicians and researchers from many of these 
institutions have visited our clinics for an insight into our way of treatment. This is an 
ongoing research initiative that has been active since 2002, though due to our access to cases 
prior to this date, we have been able to get a wider perspective from even earlier in our 
experience. 
At present, we are in the process of collaborating with researchers from the National Cancer 
Institute of the United States with the desire to mine the data and use the information to 
understand better the sphere of efficacy, as well as to fine tune our protocols. 
5.5 Cancer treatment outcomes at PBHRF with the Banerji Protocols 
In the six months prior to preparation of this manuscript, we saw a total of 1856 cancer cases 
at PBHRF. Table 2 shows the types of cancer treated during this period.  
 
TYPE OF CANCER % total cases # of cases 
BRAIN 21% 385 
LUNG 14% 260 
BREAST 7% 129 
GALL BLADDER 5% 98 
STOMACH 5% 92 
CERVIX 4% 71 
ESOPHAGUS 4% 66 
RECTUM 3% 55 
TONGUE 3% 56 
PANCREAS 2% 36 
LIVER 2% 36 
CHEEK 2% 35 
PROSTATE 2% 31 
OVARIAN 2% 31 
NON HODGKIN'S LYMPHOMA 2% 31 
OSTEOSARCOMA 1% 10 
OTHER 21% 434 
TOTAL 100% 1856 
Table 2. Types of cancer cases treated at PBHRF in 6-month period, 2010-2011 
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Our overall aggregate retrospective data collected on over 20,000 patients with all varieties 
of cancer treated over an 18-year period (Figure 1) reveals that 21% of the cancers 
completely regressed, and 23% were improved or stable. 
 
Fig. 1. Results of Treatment of 30,288 Malignant Tumor Cases (1990 – 2008) 
Retrospective data collected over a one-year period on patients treated for lung, brain and 
esophageal cancer showed that complete regressions ranged from 22 to 32% (Figure 2).  
 
Fig. 2. Results of treatment of 1132 cases of lung, brain and esophageal cancers, August 
2006-August 2007 
6. Some case studies  
We present below three cases, two of which, the lung cancer and the esophageal cancer case, 
were submitted to the National Cancer Institute of the United States for validation of the 
results, where they passed strict scrutiny and were presented before the Cancer Advisory 
Panel. 
6.1 Case 1 – Lung cancer 
Male, 47 years old, came to the clinic on 30th November 1994. He was suffering from chest pain 
with severe cough along with loss of weight for the last three months. On examination 
restricted respiratory movement on the left side with few localized crepitations were present in 
the upper part of the left chest. Chest X-ray dated the 18th of November 1994 showed “…a 
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well-defined large soft tissue density mediastinal mass in the left upper mediastinum…the 
lung fields are well expanded. Area of consolidation is seen in the left upper lobe.” (Figure 3) 
 
Fig. 3. Case 1, Chest X-ray 18.11.1994 
C.T. Scan of chest dated 19th November 1994 shows “an 8.0 cm x 6.4 cm well defined soft 
tissue mass...in upper mediastinum in left side…with air space consolidation of adjacent left 
upper lobe.” (Figure 4) 
 
 
Fig. 4. Case 1, C.T. of chest 19.11.1994 
C.T. Guided FNAC of mediastinal mass dated 24th of November 1994 showed “…malignant 
tumor.” (Figure 5) 
After undergoing treatment from us with the medicines Kali Carbonicum 200c two drops 
thrice a week and Ferrum Phosphoricum 3x two tablets twice daily, patient became 
asymptomatic. X-ray dated 31st of January 1995 showed “...considerable shrinkage in the 
mediastinal mass...” (Figure 6). 
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Fig. 5. Case 1, Histopathology 24.12.1994 
 
Fig. 6. Case1, Chest X-ray 31.1.1995 
X-ray dated 5th of July 1995 showed “….Gradual and excellent regression of the mediastinal 
mass since original X-ray of 18 November 1994.” X-ray dated 9th January 1996 described 
only a “...small residual opacity still present.” 
At the National Cancer Institute it was described as a diagnosed case of Malignant 
Neoplasm. According to TNM classification of the tumor in this case, the growth was T2, 
N1, M0 – Stage II; if it was a case of metastasis from an unknown primary, then it would be 
staged at Stage IV. Additional chest X-rays were done on several occasions. The last was on 
7th of January 1999, which showed complete resolution of the mediastinal tumor (Figure 7). 
There were no complications during treatment. We are still reviewing the case off and on 
but there has been no recurrence. 
6.2 Case 2 – Esophageal cancer 
Male, aged 75 years, was suffering for two months with difficulty in swallowing food, 
heartburn and belching, when he came to us for his treatment on 16th of December 1996. 
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Clinically the patient presented with dysphagia, heartburn and belching. His initial barium 
swallow showed almost complete obstruction of the esophagus, as shown in Figure 8. 
 
Fig. 7. Case 1, Chest X-ray 7.1.1999 
 
Fig. 8. Case 2, Barium swallow 17.10.1996   
Endoscopy done on 29th November 1996 showed “…GE junction at 40cm. At 18 cm. is a 
growth extending up to 22cm. causing luminal narrowing.” A biopsy dated 6th December 
1996 showed “…moderately differentiated Squamous Cell Carcinoma” (Figure 9). 
After undergoing treatment from us with the medicine Condurango 30c two drops twice 
daily, the patient’s symptoms were resolved within two months. Now the patient is in good 
health and does not complain of dysphagia. Post treatment barium swallow X-ray of 
esophagus dated 12th July 1997 showed   “…considerable improvement in the patency of the 
esophagus” (Figure 10). There were no complications during treatment. 
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Fig. 9. Case 2, biopsy 29.11.1996 
 
Fig. 10. Case 2, Post-treatment barium swallow 12.7.1997 
6.3 Case 3 – Osteosarcoma 
Male, aged 8 years, was suffering for 5 to 6 months with swelling in left knee and difficulty in 
flexing the knee, when he came to us for his treatment on 18th July 2003. On examination the 
patient presented with a non tender, firm to hard swelling over the left knee joint. X-ray of left 
knee joint dated 5th June 2003 showed “…a well defined eccentric lesion in metaphyses with 
sclerosis at edges - ? fibrous cortical defect/aneurismal bone cyst/lymphoma…” (Figure 11). 
The child underwent histopathological examination of the swelling and the report dated 12th 
June 2003 showed “…Section shows histology of a high grade sarcomatous lesion showing 
many mitotic figures…Poorly differentiated sarcomatous lesion…” (Figure 12). At that time 
the parents of the child were advised at the Chittaranjan National Cancer Institute, Kolkata, 
to allow immediate “…above the lesion amputation…” of the affected leg. 
After undergoing treatment from us with the medicines Symphytum 200c two doses a day, 
Calcarea Phosphorica 3X two doses a day and Carcinosin 30c one dose every alternate day, 
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the swelling gradually subsided and now the architecture of the knee has completely 
returned to normal. X-ray dated 16th December 2003 revealed “…gross healing at osteolytic 
area...” (Figure 13). 
 
Fig. 11. Case 3, X-ray 5.6.2003 
 
Fig. 12. Case 3, Histopathology 12.6.2003 
 
Fig. 13. Case 3, X-ray 16.12.2003 
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Repeat X-ray dated 14th August 2004 showed “…remineralization seen at the lower third of 
left femur...” (Figure 14). He then reduced the doses and discontinued our medication after 
four months. 
 
Fig. 14. Case 3, X-ray 14.8.2004 
7. Worldwide interest in the Banerji Protocols 
However, since 1997, there have been winds of change. It was this year when the National 
Institutes of Health (NIH) of the United States asked us to produce records of our 
successes as part of their Best Case Series programme for evaluating clinical data from 
alternative healthcare practitioners. We submitted complete records of cured cases in 
1997, and our presentation of cases was accepted after detailed scrutiny by the National 
Cancer Institute (NCI) in 1999. Subsequently, we provided a six-hour presentation before 
a 17-member Cancer Advisory Panel. This panel included cancer specialists from all the 
leading American Comprehensive Cancer Centers, including the Washington Cancer 
Institute, The University of Texas M. D. Anderson Cancer Center, The Memorial Sloan 
Kettering Cancer Center, and The Johns Hopkins Medical Center. The panel accepted our 
presentation unanimously, and this was indeed a great victory for homeopathy (Banerji, 
2008).  
Since then we have had many visitors from the United States including: Dr. Jeffrey White, 
MD, Director, Office of Cancer Complementary and Alternative Medicine, National Cancer 
Institute; Dr. Moshe Frenkel, Associate Professor of Integrative Medicine and Medical 
Director of the Integrative Medicine Program, Division of Cancer Medicine Department of 
Palliative Care and Rehabilitation Medicine at the University of Texas M D Anderson 
Cancer Center; Dr. Elena Ladas, MS, RD, Director, and Dr. Kara M. Kelly, MD, Medical 
Director of the Integrative Therapies Program for Children with Cancer, Division of 
Pediatric Oncology, and others from Columbia University; and Dr. Barbara Sarter, now at 
the University of San Diego, who spent five months in Kolkata to study the Banerji Protocols 
and work with us when she held a faculty position in the Department of Family Medicine at 
the University of Southern California; she has a long background in conventional medicine, 
and also a degree in classical homeopathy. 
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An important aspect of the PBHRF’s activities is research, and under its banner, 
Drs. Banerji have been involved in recent years in collaborative research projects with 
American institutes of international renown which include the University of Texas M. D. 
Anderson Cancer Center, Columbia University, and the University of Kansas Medical 
Center. Since 1977, Drs. Banerji have been invited to a large number of prestigious 
international conferences, symposia, seminars and meetings to deliver lectures, present 
papers, or discuss important aspects of their work. Patients from more than 70 countries at 
present follow the Banerji Protocols through the website www.pbhrfindia.org, seeking 
online medical advice and treatment.  
Spain has assumed great importance for our work in recent years. In 2008, a three-
member cancer support team from Spain undertook a week-long visit to PBHRF to 
acquire firsthand knowledge about the Banerji Protocols; two hold senior positions at the 
University of Barcelona, while the third runs a Valencia-based web portal for cancer 
support, which is visited by nearly 1000 persons daily, not only in Spain, but also in 
Spanish-speaking countries elsewhere in the world – with many enquiries on the Banerji 
Protocols. 
The response of Spanish homeopaths, pharmacists and patients to the Banerji Protocols has 
been extremely enthusiastic. In 2008, Drs. Banerji made a presentation at a conference 
exclusively for classical homeopaths who enthusiastically welcomed the Banerji Protocols. A 
documentary film on Dr. Prasanta Banerji is now being made by two Spanish documentary 
film makers who have undertaken visits to Kolkata and Mihijam. 
In 2009, Drs. Banerji visited Japan twice, and there are excellent prospects for the 
popularization of treatment in this country using the Banerji Protocols. They are scheduled 
to visit again by invitation from the Royal Academy of Homeopathy, for more seminars in 
October 2011. 
8. Conclusion: Winds of change 
Compared to conventional medicine, homeopathy has always suffered from a lack of 
credibility and recognition the world over, having been acceptable only to those who cannot 
afford the high costs of conventional medical treatment. However, since 1977, there have 
been winds of change. There has, on the one hand, been a perceptible lack of success of 
conventional medicine to cure various ailments and diseases – notably cancer - and, on the 
other, the serious – and growing – concern of researchers to identify options for medical 
treatment offered by various streams of alternative medicine, including homeopathy. It is 
here that the Banerji Protocols of treatment, based on the use of homeopathic medicines, 
have had an important role to play. Dr. Prasanta Banerji and Dr. Pratip Banerji, along with 
their assistants, together attend 1000 to 1200 patients every day, including 300 to 400 
patients at their free clinic, in Kolkata. By so doing, they keep up the tradition of their 
revered forefathers, help make the Banerji Protocols a mode of medical treatment for the 
masses – the second important objective of the PBHRF — and ensure the collection, 
documentation and use in meaningful research in the years to come. The operations of the 
PBHRF and the development of the Banerji Protocols have been giving homeopathy a 
scientific basis and making it eligible for scientific research.  
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8.1 Looking at the future 
To meaningfully serve medical science and humanity, homeopathy required a rebirth. 
Perhaps nothing can provide this better than the Banerji Protocols and the work of the 
PBHRF, both aimed at making homeopathy with the use of the Banerji Protocols 
scientifically acceptable. 
Opposition to the Banerji Protocols and the work of the PBHRF from the scientific 
community and followers of classical homeopathy notwithstanding, everything augurs well 
for the rebirth of homeopathy. Much is required to make the Banerji Protocols and the role 
of the PBHRF known everywhere in the world.  
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